Efficacy of weekly transtuzumab and paclitaxel in the treatment of women with HER-2/neu overexpressing metastatic breast cancer. The impact of taxane free interval on treatment outcomes | Charles Explorer

Efficacy of weekly transtuzumab and paclitaxel in the treatment of women with HER-2/neu overexpressing metastatic breast cancer. The impact of taxane free interval on treatment outcomes

Publikace na 1. lékařská fakulta |

2002

Abstrakt

Transtuzumab, paclitaxel, metastatic breast cancer

Osoby